LYRA THERAPEUTICS INC (LYRA:NASDAQ)
$0.7 -0.08 (-10.2564%)
Analysed LYRA THERAPEUTICS INC (LYRA:NASDAQ) News Sources
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
12-08-2025
yahoo.com
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study
06-10-2025
yahoo.com
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
04-11-2025
yahoo.com
Dentsply International (XRAY) Lags Q3 Earnings Estimates
06-11-2025
yahoo.com
Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates
10-11-2025
yahoo.com
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
12-11-2025
yahoo.com
Lyra Therapeutics Provides Corporate Update
12-01-2026
yahoo.com
Top Midday Decliners
12-01-2026
yahoo.com
Lyra Therapeutics suspends further development of LYR-210
13-01-2026
yahoo.com
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
17-04-2026
yahoo.com
What is the current price of LYRA THERAPEUTICS INC (LYRA:NASDAQ)?
The current price of LYRA THERAPEUTICS INC (LYRA:NASDAQ) is $0.7.
LYRA THERAPEUTICS INC (LYRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of LYRA THERAPEUTICS INC (LYRA:NASDAQ) since the previous trading day is $-0.08.
LYRA THERAPEUTICS INC (LYRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of LYRA THERAPEUTICS INC (LYRA:NASDAQ) since the previous trading day is -10.2564%.
What is the most recent average sentiment score for LYRA THERAPEUTICS INC (LYRA:NASDAQ)?
The most recent average sentiment score for LYRA THERAPEUTICS INC (LYRA:NASDAQ) is 27 out of 100.
What is the most recent average sentiment for LYRA THERAPEUTICS INC (LYRA:NASDAQ)?
The most recent sentiment for LYRA THERAPEUTICS INC (LYRA:NASDAQ) is .
SEC-8K** Filing Available For LYRA THERAPEUTICS INC (LYRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.